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Background: In the retina, insulin-like growth factor I (IGF-I) is neuroprotective and essential for vasculature homeostasis.
Results: Transgenic mice overexpressing Igf-I in the retina present chronic gliosis and retinal stress leading to
neurodegeneration.
Conclusion: IGF-I induces deleterious processes in the retina that, chronically, may overcome its neurotrophic properties.
Significance: Increased intraocular IGF-I may contribute to the pathogenesis of conditions such as ischemic or diabetic
retinopathies.
Insulin-like growth factor I (IGF-I) exerts multiple effects on
different retinal cell types inbothphysiological andpathological
conditions. Despite the growth factor’s extensively described
neuroprotective actions, transgenic mice with increased intra-
ocular levels of IGF-I showed progressive impairment of elec-
troretinographic amplitudes up to complete loss of response,
with loss of photoreceptors and bipolar, ganglion, and amacrine
neurons. Neurodegeneration was preceded by the overexpres-
sion of genes related to retinal stress, acute-phase response, and
gliosis, suggesting that IGF-I altered normal retinal homeosta-
sis. Indeed, gliosis and microgliosis were present from an early
age in transgenic mice, before other alterations occurred, and
were accompanied by signs of oxidative stress and impaired glu-
tamate recycling. Older mice also showed overproduction of
pro-inflammatory cytokines. Our results suggest that, when
chronically increased, intraocular IGF-I is responsible for the
induction of deleterious cellular processes that can lead to neu-
rodegeneration, and they highlight the importance that this
growth factor may have in the pathogenesis of conditions such
as ischemic or diabetic retinopathy.
IGF-I4 is a growth factor with mitogenic, differentiating,
anti-apoptotic, andmetabolic functions (1) that also plays a key
role in pathological retinal neovascularization (2). IGF-I is
increased in the vitreous of patients with proliferative ocular
diseases, such as diabetic retinopathy (3), and pharmacological
inhibition or genetic deletion of the Igf-I receptor in the retinal
vasculature of rodents prevent neovascularization under
hypoxic conditions (4, 5). Similarly, in humans, mutations in
genes coding for the growth hormone receptor, Igf-I, or Igf-I
receptor are associatedwith reduced retinal neovascularization
(6). IGF-I is a potent inductor of the expression of the pro-
angiogenic factor VEGF, through hypoxia-inducible factor 1
stabilization (7). In addition to the effects on VEGF transcrip-
tion, IGF-I may act cooperatively with VEGF to stabilize newly
formed vessels (4).
Besides its actions on retinal vasculature, IGF-I is a pro-sur-
vival molecule that can act on neurons (8). Humans carriers of
homozygous mutations associated with reduced expression of
the Igf-I gene present mental retardation and deafness, associ-
ated with severe prenatal growth retardation, postnatal growth
failure, and microcephaly, confirming the role of IGF-I as a
neurotrophic factor (9, 10). Because of these properties, IGF-I
has been used to counteract neurodegeneration in experimen-
tal animal models of brain injury (11) and retinal neurodegen-
eration (12). Moreover, IGF-I-deficient mice develop slow ret-
inal neurodysfunction with loss of ERG responses (13). This
evidence demonstrates that IGF-I plays an important role in
neuronal development and survival.
Transgenic mice overexpressing Igf-I in photoreceptors
(TgIGF-I) have increased intraocular VEGF levels and develop
many of the retinal vascular alterations characteristic of human
diabetic eye disease, despite not being hyperglycemic (14, 15).
Nonproliferative vascular alterations are found in young ani-
mals (2–3months), and the phenotype progresses to overt pre-
retinal neovascularization in adult mice (7–8 months) (14).
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VEGF, which plays a pivotal role in the development of prolif-
erative retinopathies (16), is expressed by glial cells in trans-
genic retinas, the cell type that also overproduces this factor in
diabetic patients (17). Gliosis is observed in Igf-I -overexpress-
ing retinas at nonproliferative stages, before neovascularization
occurs, suggesting that Igf-I overexpression is likely causing
other alterations on transgenic retinas that contribute to the
phenotype.
Given the apparently antagonistic effects of IGF-I on the ret-
ina, with deleterious effects on retinal vasculature (6) but posi-
tive effects on neuronal survival (12), we evaluated the conse-
quences of the chronic elevation of intraocular IGF-I on retinal
functionality in TgIGF-I mice. We observed a progressive
decline in ERG amplitudes in transgenic animals, leading to
complete loss of response in old animals. This study demon-
strates that the chronic overproduction of IGF-I in the retina
induces a series of deleterious cellular processes, independent
of neovascularization, that eventually surpass IGF-I pro-sur-
vival properties leading to neurodegeneration.
EXPERIMENTAL PROCEDURES
Animals—CD1 heterozygous mice overexpressing Igf-I in
the retina were used (14). Animal care and experimental pro-
cedures were approved by the Ethics Committee in Animal
and Human Experimentation of Universitat Autònoma de
Barcelona.
Electroretinography—ERG recordings were performed in
deeply anesthetized and dark-adapted mice. Recordings were
taken between a mouse electrode fixed on a corneal lens over
the mouse eye (Burian-Allen electrode, Hansen Ophthalmic
Development Lab), a reference electrode located in the mouth,
and a ground electrode located in the tail. After pupil dilatation,
flash-induced ERG responses were recorded from the right eye
in response to light stimuli produced with a Ganzfeld stimula-
tor. Light stimuli intensities ranged from4 to 2 log cdsm2
and, for each intensity, 4–64 consecutive light presentations
were averaged. Each range of flashes allowed recording of par-
ticular responses as follows: from 4 to 1.52 for rod-medi-
ated responses; from 1.52 to 0.48 for mixed rod and cone
responses; 0.48 and at a recording frequency range of 100–1000
Hz for oscillatory potentials; from0.52 to 2 log cdsm2 on a
rod-saturating background of 30 cd/m2 for cone-mediated
responses; and at 1.48 log cdsm2 on a rod-saturating back-
ground for flicker responses (20 Hz). The ERG signals were
amplified, band filtered between 0.3 and 1000Hz (Grass CP511
AC amplifier), and digitized at 10 kHz with a Power Lab data
acquisition board (ADI Instruments). ERGmeasurements were
taken by an observer blinded to the experimental conditions of
the animals.
Histological Analysis—Formalin-fixed, paraffin-embedded
eye sections were incubated with tomato lectin Lycopersicon
esculentum (Sigma), anti-rhodopsin (Abcam, Cambridge, UK),
anti-calretinin (Invitrogen), anti-PKC (Sigma), anti-Brn3a
(Santa Cruz Biotechnology, Santa Cruz, CA), GFAP (Dako
Cytomation, Glostrup, Denmark), and anti-cleaved caspase3
(Cell Signaling,Danvers,MA).Nucleiwere counterstainedwith
DAPI (Sigma) Images were obtained with a laser-scanning con-
focal microscope (TCs SP2; Leica Microsystems GmbH, Wet-
zlar, Germany) or a Nikon Eclipse 90i microscope (Nikon
Instruments Inc., Tokyo, Japan).
Morphometric Analysis—Retinal layers (INL and ONL)
lengthwasmeasuredwithNIS Elements software (Nikon) in six
central and six peripheral images (20) from retinal sections
showing the optic nerve. Three measurements were performed
in each image for each layer, ensuring perpendicular distances
between layer limits. The length of the posterior segment of rod
photoreceptors was determined by the same method in central
sections. For quantification of specific neuronal populations,
total positive cells were counted per 20 images of central retinal
sections with optic nerve.
Microarray Samples and Analysis—The protocol for RNA
extraction recommended by Affymetrix was followed (Expres-
sion Analysis Technical Manual). Microarray analysis was
performed by Progenika (Bilbao, Spain). The final gene list con-
tained only those probe sets with a p  0.05. For the interpre-
tation, cross-checking, and visualization of the data, FatiGO
Term Enrichment (release date Nov. 20, 2010), Database for
Annotation, Visualization, and Integrated Discovery (DAVID,
david.abcc.ncifcrf.gov), and Kyoto Encyclopedia of Genes and
Genomes (KEGG database), and GeneCodis were used. Array
data have been submitted to GEO database (accession number
GSE46246).
RNA Extraction and Quantitative Real Time PCR—Retinas
were homogenized in 200 l of Tripure (Roche Applied Sci-
ence), and retinal RNA was purified using RNeasy mini kit
(Qiagen Sciences, Germantown, MD). cDNA was synthesized
with transcriptor first strand cDNA synthesis kit (Roche
Applied Science). Quantitative real time PCR was performed
using LightCycler 480 SYBR Green I Master (Roche Applied
Science) with specific primers.
Protein Analysis—For Western blot, retinas were homoge-
nized in lysis buffer and 50–100 g of retinal extract were
separated by 12%SDS-PAGE. Immunoblotwas performedwith
anti-acetyl-NF-B (Cell Signaling), anti-ERK1/2 (Cell Signal-
ing), anti-phospho-ERK1/2 (Cell Signaling), anti-GFAP
(DAKO Cytomation), anti-MCP-1 (Abcam), or anti-tubulin
(Abcam). Detection was performed using Immobilon Western
reagent (Millipore). The pixel intensity of the bands obtained
was determined with GeneSnap software for Gene Genius Bio
Imaging System (Syngene, Synoptics Ltd.), and the ratio protein
content/tubulin content was calculated for each sample to
allow loading-independent comparison.
Retinal Explants—Wild-type C57 mice were sacrificed, and
eyes were enucleated. Retinas were dissected and incubated in
DMEM (reference E15-810, PAA) complemented with 10%
FBS (PAA, ref. A15–151) and antibiotic/antimycotic (PAA, ref.
P11–002) at 37 °C and 5% CO2. Medium was refreshed 24 h
later. After 48 h, recombinant IGF-I (Sigma) was added to
DMEMwithout FBS. Between 2 and 5 h prior to IGF-I addition,
5 l of 200 M wortmannin (Sigma) or DMSO (Sigma) were
added to the culture media. After 48 h of stimulation, retinas
were collected and frozen at80 °C for total RNA isolation.
Glutamine Synthetase Activity and Oxidized Glutathione—
Protein extracts were obtained as for Western blot analysis. 40
l of a 1:10 dilution of the extracts was added to the reaction
mixture containing 50 mM sodium glutamate (Sigma), 20 mM
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MgCl2, 15 mM ATP (Sigma), 100 mM imidazole, pH 7.2, 1 l of
-mercaptoethanol, 10 mM creatine phosphate (Sigma), 1 l of
creatine phosphokinase (Sigma). After 1–2 min of preincuba-
tion of the mixture at 37 °C, the reaction was started by adding
8 l of 125 mM hydroxylamine. Ten minutes later, the reaction
was stopped with 120 l of ferric chloride solution (0.37 M
FeCl3, 0.67MHCl, 0.20M trichloroacetic acid) and placed on ice
for 5 min. Afterward, the supernatant was collected from the
wells, and absorbance was measured at 525 nm. Values were
corrected by protein content of each sample and represented as
percentage of wild-type values. Oxidized glutathione was mea-
sured in retinal extracts using the glutathione (total) detection
kit from Enzo Life Sciences (catalog no. ADI-900-160) follow-
ing the manufacturer’s instructions.
Statistical Analysis—Values are expressed as themean S.E.
Differences between groups were compared by unpaired Stu-
dent’s t test. Differences were considered statistically signifi-
cant at p values less than 0.05.
RESULTS
Neuronal Dysfunction in Transgenic Retinas Overexpressing
IGF-I—Retinal neurophysiology was assessed in wild-type
(WT) and TgIGF-I mice through ERG studies. Both rod and
cone-driven responses were evaluated by performing measure-
ments in scotopic and photopic conditions, respectively. At 3
months of age, transgenic mice did not show any difference in
comparison with WT littermates in the amplitudes of the
responses obtained with different light intensities (Fig. 1,A–F).
At 6 months of age, however, responses were heterogeneous
among different animals (Fig. 1,A–F). The abnormal responses
in TgIGF-I mice became statistically significant at 7.5 months
of age (Fig. 1,A–F). By 9months of age, the average response in
transgenic mice was reduced to about 20% of that recorded in
WT animals (Fig. 1, A–F). Clearly, retinal dysfunction was pro-
gressive, from normal responses at 3 months of age to almost
complete loss of response by 9 months.
To evaluate if this progressive retinal neurodegenerationwas
the consequence of the development of neovascularization,
young (1.5-month-old) TgIGF-I mice were treated intravitre-
ally with adenoassociated viral vectors carrying the gene of
pigment epithelium-derived factor (PEDF), a well known anti-
angiogenic factor (18). This treatment leads to long term pro-
duction of PEDF, normalization of intraocular levels of VEGF,
andprevention of neovascularization and retinal detachment in
this animal model (19). However, the evaluation of ERG
responses at 7.5 month of age, i.e. 6 months after gene transfer,
did not reveal any recovery in PEDF-treated animals (Fig. 1G),
suggesting that vascular alterations were not the main mecha-
nism underlying neurodegeneration in transgenic retinas.
Decreased Thickness of Retinal Layers in Transgenic Mice—
The thickness of retinal layers is a general indicator of the loss of
neuronal populations. ONL and INL thicknesses were quanti-
fied in both the peripheral and central areas of retinal sections
containing the optic nerve (Fig. 2A). In agreement with func-
tional observations, at 3 months, the thickness of retinal layer
was preserved in TgIGF-I retinas and only a slight, nonstatisti-
cally significant decreasewas observed in 6-month-old animals,
mainly in the ONL (data not shown). At 7.5 months of age,
retinas of TgIGF-I mice were clearly thinner, with a 40% reduc-
tion in the width of both ONL and INL (Fig. 2A). These results
suggest that a chronic increase in intraocular IGF-I levels
resulted in neurodegeneration of photoreceptors and other
neuronal cells.
FIGURE 1. Progressive alteration of electroretinographic responses in
transgenicmicewith increased intraocular IGF-I. A–F, evolution over time
of ERG responses in TgIGF-I mice (pink lines) compared with healthy litter-
mates (black lines). With age, TgIGF-I showed a progressive decline in the
recorded amplitudes in response to all stimuli tested. A, scotopic threshold
response, representing highly sensitive responses of rod photoreceptors;
B, scotopic b-wave, representing rod responses; C,mixed scotopic, reflecting
stimulation of both rod and cones under scotopic conditions; D, oscillatory
potentials, which measure INL neuronal activity; E, photopic b-wave, depict-
ing cone responses; F, flicker, repetitive photopic stimulations that analyze
cone recovery. Therewere statistically significant reductions in the responses
in animals aged more than 7.5 months. G, ERG responses were recorded 6
months after a single intravitreal administration of AAV2-hPEDF (left eye)
and AAV2-null (right eye) vectors to TgIGF-I mice aged 1.5 months. Age-
matchedWT littermateswere used as controls. Scotopic b-wave (Bscot),mixed
a and b-waves, oscillatory potentials, and photopic b-wave (Bphot) were ana-
lyzed. Despite the counteraction of retinal neovascularization, the overex-
pression of PEDF was not able to ameliorate the electroretinographic
responses of treated eyes, which presented reduced amplitudes in all tests
performed, similar to those of null-injected, untreated eyes. Values are
expressed as the mean S.E. of 5–9 animals/group. *, p0.05; **, p0.01;
***, p0.001.
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Loss of SpecificNeuronal Populations inTgIGF-I Retinas—To
identify which type of neurons was degenerating in transgenic
retinas, specific markers were used to detect and quantify dif-
ferent neuronal populations in 7.5-month-old animals. The
length of rod photoreceptor outer segment was markedly
reduced in transgenic retinas, as determined by morphometric
analysis on rhodopsin-immunostained sections (Fig. 2B). Nev-
ertheless, TgIGF-I retinas had normal cone arrestin content
(data not shown), indicating that cone photoreceptors were not
altered. Collectively, these observations suggested that the
reducedONL thickness observed (Fig. 2A) was likely due to the
loss of rods, as rods and cones are the only cell types found in
this nuclear layer.
Bipolar and amacrine neurons specifically express the - iso-
form of protein kinase C (PKC) and calretinin, respectively.
Retinal sections from 7.5-month-old TgIGF-I animals had a
FIGURE 2. Reduced thickness of the different retinal layers and decreased neuronal populations in IGF-I-overexpressing retinas. A, thickness of retinal
layers was measured at 7.5 months of age. Retinal layers were clearly thinner in TgIGF-I mice, with statistically significant reductions in both ONL and INL
thickness in central and peripheral retina. B–E, representative images of the immunolabeling of retinal sections with specific neuronal markers (left) and
quantification of labeled populations (right) in 7.5-month-oldWT and TgIGF-I mice. B, rhodopsin immunolabeling (red) showing positive staining in the outer
segment (OS) of photoreceptors. Outer segment length (arrows) was measured in medial retinal sections. The length of the outer segment was significantly
reduced in transgenic retinas.C, representative images of PKC immunostaining (green). The terminals of bipolar cells located in the outer and inner plexiform
layers (upper and lower insets) were strongly positive in WT retinas. Cell bodies spanning from the INL to the GL were also labeled. Transgenic retinas showed
reduced PKC reactivity. Quantification of the number INL PKC-positive cells revealed a significant loss of bipolar PKC cells in transgenic mice.D, represent-
ative images of calretinin immunolabeling (green) showing reduced staining in both theGL and the INL in TgIGF-I. Quantification of the number of calretinin
cells demonstrated a reduction in the number of amacrine neurons in transgenic retinas. E, immunofluorescent detection of Brn3a (green), expressed specif-
ically in the nuclei of ganglion neurons (arrowheads). Transgenic retinas showed fewer Brn3a positive nuclei in the GL. Nuclei were counterstained with DAPI
(blue). Values are expressed as the mean S.E. of 5–9 animals/group. *, p0.05; **, p0.01. Scale bar, (A) 35.51 m; B–E, 18.37 m.
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reduced number of PKC cells and calretinin neurons (Fig.
2, C and D), in agreement with a thinner INL (Fig. 2A). Bipolar
cells were the only cell type for which we detected a statistically
significant reduction at earlier time points (6 months, data not
shown). No differences were observed in the number of hori-
zontal neurons (data not shown). Finally, the number of gan-
glion cells with positive immunostaining for the transcription
factor Brn3a was also lower (Fig. 2E). Immunofluorescent
detection of cleaved caspase-3, a marker of apoptosis, revealed
few caspase-3 cells in the GL of transgenic retinas (Fig. 3).
These findings, together with the decline in ERG responses,
suggested there was a progressive loss of neurons in transgenic
retinas.
Analysis of Gene Expression in Young Transgenic Retinas—
To identify the changes in gene expression that could account
for the neuronal dysfunction induced by increased intraocular
IGF-I, we performed microarray analysis on total retinal RNA
from 4-month-old animals. At this age, transgenic retinas do
not yet show neurodegeneration but only evidence of nonpro-
liferative vascular alterations and gliosis (14). After data nor-
malization and filtering, we detected 37 genes differentially
expressed in transgenic retinas, of which 25 were up-regulated
and 12were down-regulatedmore than 1.5-fold (Table 1).Most
of the up-regulated genes were classified in three main catego-
ries as follows: retinal stress, gliosis, and angiogenesis, whereas
down-regulated genes were mostly associated with angiogene-
sis and CNS development. Several of the up-regulated genes in
the category of retinal stress corresponded to acute-phase pro-
FIGURE 3. Detection of apoptotic cells in the retinas of transgenic mice
with increased intraocular IGF-I. Cells positive for the apoptosis marker
cleaved caspase 3 (green, arrows) were found in the ganglion cell layer of
transgenic retinas at 6 months of age. Cleaved caspase 3-positive cells could
not be detected in retinal sections from age-matched wild-type animals.
Nuclei were stained with DAPI (blue). Scale bar, 7.6 m (left panel), and 11.43
m (right panel).
TABLE 1
Microarray expression analysis in young transgenic mice
Classification of up- and down-regulated genes in retinas of 4-month-old IGF-I transgenic mice according to their biological function reported in the literature. Up-reg-
ulated genes (1.5-fold change) were classified in threemain categories as follows: retinal stress, gliosis, and angiogenesis. Down-regulated genes (1.5-fold change) were
classified in two main categories, angiogenesis and CNS formation.
Gene description Gene symbol Fold change p value RefSeq
Stress (retinal stress)
Nuclear protein 1 Nupr1 2.03 0.0003 NM_019738
Lipocalin 2 Lcn2 2.00 0.0013 NM_008491
Oncostatin M receptor Osmr 1.59 0.0039 NM_011019
Interferon-induced transmembrane protein 3 Ifimt3 1.58 0.0050 NM_025378
Complement component 4b C4b 1.76 0.0084 NM_009780
2-Macroglobulin A2m 1.73 0.0090 NM_175628
Complement component 1, q subcomponent, -polypeptide C1qa 1.55 0.0095 NM_007572
Inhibitor of DNA binding 2 Id2 1.70 0.0214 NM_010496
Histidine decarboxylase Hdc 1.50 0.0260 NM_008230
Endothelin 2 Edn2 2.00 0.0497 NM_007902
Gliosis
Glial fibrillary acidic protein Gfap 3.10 0.0014 NM_010277
S100 protein,  polypeptide S100b 2.02 0.0060 NM_009115
Doublecortin-like kinase 1 Dclk1 1.54 0.0111 NM_019978
Gap junction protein, 1 Gja1 2.06 0.0173 NM_010288
Aquaporin 4 Aqp4 1.52 0.0199 NM_009700
Angiogenesis
Carbonic anhydrase 3 Car3 1.59 0.0005 NM_007606
EGF-containing fibulin-like extracellular matrix protein 1 Efemp1 1.52 0.0056 NM_146015
Rac GTPase-activating protein 1 Racgap1 1.53 0.0068 NM_012025
2-Macroglobulin A2m 1.73 0.0090 NM_175628
Procollagen C-endopeptidase enhancer protein Pcolce 1.60 0.0215 NM_008788
Polycystic kidney disease 1 homolog Pkd1 1.58 0.0272 NM_013630
Progesterone receptor membrane component 2 Pgrmc2 1.58 0.0348 NM_027558
Rho-guanine nucleotide exchange factor Rgnef 3.45 0.0426 NM_012026
CNS formation
Nardilysin, N-arginine dibasic convertase, NRD convertase 1 Nrd1 1.54 0.0002 NM_146150
Sema domain, immunoglobulin domain (Ig), short basic domain Sema3f 1.52 0.0354 NM_011349
Cut-like homeobox 2 Cux2 1.54 0.0426 NM_007804
Miscellaneous
Keratin 18 Krt18 1.65 0.0027 NM_010664
CDK2 (cyclin-dependent kinase 2)-associated protein 1 Cdk2ap1 1.89 0.0027 NM_013812
2-Microglobulin B2m 1.52 0.0086 NM_009735
Actin, 2, smooth muscle, aorta Acta2 1.51 0.0107 NM_007392
Hemoglobin , adult chain 1 Hba-a1 1.66 0.0206 NM_008218
Hemoglobin , adult chain 2 Hba-a2 1.66 0.0206 NM_001083955
RIKEN cDNA 1200015N20 gene 1200015N20Rik 1.55 0.0325 NM_024244
Chromodomain helicase DNA-binding protein 7 Chd7 1.55 0.0343 NM_001081417
RIKEN cDNA 5830417I10 gene 5830417I10Rik 2.23 0.0345 NM_027389
Mitochondrial ubiquitin ligase activator of NFKB 1 Mul1 2.32 0.0491 NM_026689
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teins, such as 2-macroglobulin, lipocalin2, and components of
the complement system.Microarray results were confirmed by
quantitative PCR, and the expression of up-regulated geneswas
studied at different ages to identify the onset of each response
(Fig. 4A). For most genes, expression was increased already by
1.5 months of age, and this rise was maintained or even exacer-
bated through the animal’s life (Fig. 4A). Gliosis-related genes,
includingGfap, S100b, andGja1, showed an up-regulation pat-
tern parallel to that of stress and acute-phase protein genes
(Fig. 4A). Some of these genes were already up-regulated in
retinas from transgenic animals as young as 3 weeks old (Fig.
4B). The expression of the transcription factor CEBP-, one
of the main transcriptional activators of acute-phase genes
(20), was also increased in transgenic retinas (1.35-fold
increase, GEO GSE46246). CEBP- up-regulation was con-
firmed by quantitative RT-PCR in both young and old trans-
genic mice (Fig. 4C).
By performing functional analysis using the GeneCodis web
tool (21), we found in the promoter of genes whose expression
was altered in the chip analysis a significant enrichment in tar-
get sequences for a specific set of transcription factors (listed in
Fig. 4D). This analysis revealed that 10.31% of the genes modi-
fied in TgIGF-I retinas presented binding sites for CEBP tran-
scription factors, in agreementwithCEBP- up-regulation (Fig.
4C). The GeneCodis analysis also revealed that 6.25% of the
altered genes had in their promoters target sequences for
NF-B, another transcription factor implicated in the activa-
tion of acute-phase proteins (22). Although we were unable to
detect any differences at 3 months of age (data not shown), the
content of the acetylated form of NF-B, which is the active
form in the nucleus, was increased by 20% in transgenic retinas
at 7.5 months of age (Fig. 4E).
Progression of Gliosis andMicrogliosis in Transgenic Retinas—
The results of the microarray analysis agreed with our previous
FIGURE 4.Retinal gene expression profile in young TgIGF-Imice. A, analysis of the expression of gliosis, retinal stress, and acute-phase-related genes inWT
and transgenic retinas at different ages. Values are expressed asmean S.E. of three animals/group. *,p0.05; **,p0.01; ***,p0.001, $,p0.0001. B,Gfap,
S100B, Edn2, and C4bwere already up-regulated in 3-week-old transgenic retinas when analyzed by quantitative PCR. Values are expressed asmean S.E. of
four animals/group. *, p 0.05; **, p 0.01; ***, p 0.001. C, quantitative RT-PCR analysis of the expression of the transcription factor CEBP- in WT and
transgenic retinas at the indicated ages. Statistically significant increases in the expression of CEBP-were observed in transgenic retinas at 3 and 7.5 months
of age. Values are expressed as themean S.E. of 4–5 animals/group.*, p0.05.D, functional analysis of significant enrichment in the target sequences for a
specific set of transcription factors in the genes with altered expression in the microarray using the GeneCodis software. The table shows the percentage of
altered genes whose promoters contained target sequences for the indicated transcription factors. E, retinal content of the acetylated, nuclear form of NF-B
(a-NF-B) at 7.5months of age. tub, tubulin. Transgenicmice presentedhigher levels of acetyl-NF-Bwhen comparedwith age-matchedWT retinas, indicating
activation of this pathway. Values are expressed as mean S.E. of 2–6 animals/group. *, p0.05.
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reports describing the presence of gliosis in the retinas of
TgIGF-I mice (14, 15). To determine whether there is a tempo-
ral progression of glial alterations, GFAP immunohistochemis-
try was performed at different ages. We observed increased
GFAP staining in both astrocytes and Müller cells in TgIGF-I
animals as young as 1.5 months of age, and this GFAP up-reg-
ulation was maintained and even intensified throughout the
animal’s life (Fig. 5A). Quantification by Western blot con-
firmed amarked increase inGFAP retinal content from an early
age (Fig. 5B). Another cellular response characteristic of acti-
vated Müller cells is activation of the ERK1/2 pathway (23). In
agreement with the presence of gliosis in TgIGF-I mice, a
modest but statistically significant increase in the phosphor-
ylated form of ERK was observed in 3-month-old animals,
with very evident activation of ERK signaling in old animals
(Fig. 5C).
Microglial cells are resident macrophages of the retina and
become activated upon retinal injury (24). IGF-I induces prolif-
FIGURE 5. Progression of gliosis andmicrogliosis in TgIGF-I retinas. A, GFAP immunofluorescent detection (green) in retinal sections fromWT and TgIGF-I
mice at different ages. At all ages analyzed, transgenic retinas showed overexpression of GFAP, especially in radial Müller cells processes spanning the entire
retina (arrows), where GFAP is hardly expressed. This pattern of GFAP staining indicated the presence of reactive gliosis in transgenic retinas. Nuclei were
stainedwith DAPI (blue). Scale bar, 31.27m. B,GFAP content was analyzed byWestern blot in retinal extracts fromWT and TgIGF-I mice at the indicated ages.
Quantification of blots demonstrated that GFAP levels were increased in transgenic retinas at all ages. AU, arbitrary units. Values are expressed asmean S.E.
of two animals/group. *, p0.05.C, ERKphosphorylationwas analyzedbyWestern blot in retinal extracts fromWTand TgIGF-Imice at 3 and 7.5months of age.
After normalization by total ERK levels, quantification of blots showed that P-ERK levelswere increased in transgenic retinas at both ages. Values are expressed
as mean S.E. of four animals/group. *, p0.05. D, immunofluorescent detection with tomato lectin (Lycopersicum esculentum) allowed the identification of
microglial cells in retinal sections. The number of lectin-positive cells per sectionwas determined in retinal sections fromWTand transgenic retinas at different
ages, showing statistically significant differences in retinas of mice aged 3 months and older. Values are expressed as mean S.E. of four animals/group. *, p
0.05; **, p 0.01. E, representative images obtained from transgenic retinas at 7.5 months of age. Arrow indicates a round-shaped lectin cell, likely an
activatedmicroglial cell, andarrowheads indicate amicroglial cellwith characteristic stellar shapeanddendriform ramifications. Scale bar,12.06m(left panel),
8.54 (right panel).
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eration and activation ofmicroglial cells in retina and brain (25,
26). We previously reported that old TgIGF-I mice had
increased numbers of bone marrow-derived microglia (15).
When analyzed by staining with tomato lectin, we found that
the number of microglial cells was higher in TgIGF-I retinas at
all ages, confirming increased microglial infiltration starting
early in the animal’s life (Fig. 5D). Moreover, few of the tomato
lectin-positive cells showed a rounded shape, a characteristic
morphology of activated microglia (Fig. 5E, insets).
Gliosis Is a Direct Consequence of IGF-I Signaling—Further
confirmation of the direct effects of IGF-I on retinal glial cells
was obtained by culturing retinas isolated fromWT mice with
different concentrations of recombinant IGF-I protein. After
48 h of exposure to 100 ng/ml IGF-I, therewas a nonstatistically
significant increase in retinal expression of Gfap over levels of
untreated retinas, which became clearly significant (about
4-fold)when incubatedwith 200ng/ml, suggesting a direct acti-
vation of glial cells by IGF-I (Fig. 6A). This effect was abrogated
in the presence of wortmannin, a specific inhibitor of PI3K, a
downstream effector of IGF-I signaling pathway (Fig. 6A). A
similar pattern of IGF-I-mediated up-regulation was observed
when the expression of S100b was analyzed (Fig. 6B). These
data clearly demonstrate the link between IGF-I signaling and
gliosis.
Increased Oxidative Stress in IGF-I-overexpressing Retinas—
Oxidative stress, which can potentially cause neurodegenera-
tion, is especially likely to occur in the retina due to the tissue’s
constant exposure to radiation and its high oxygen consump-
tion. Glutathione acts as a scavenger of free radicals and reac-
tive oxygen species (ROS) (27). In the retina, glutathione is pro-
duced mostly by Müller cells and astrocytes, which rapidly
release it to provide neurons with antioxidant equivalents in
situations of oxidative stress (27). The levels of oxidized gluta-
thione were increased from an early age in TgIGF-I (Fig. 7A).
Moreover, the expression of Nrf2, a transcription factor that
activates a battery of antioxidant and cytoprotective genes (28),
was also increased in transgenic retinas (Fig. 7B). NADPH oxi-
dase is one of the main enzymes involved in the production of
ROS inmicroglia, astrocytes, and neurons (29). The expression
of NADPH oxidase regulatory subunits, p67Phox and p22Phox,
was up-regulated in transgenic retinas (Fig. 7, C and D).
Depending on the cell type, NADPH oxidase can be formed by
different catalytic subunits such as Nox1, Nox2, and Nox4 (29).
All three subunits were strikingly up-regulated in transgenic
retinas at 7.5 months of age (Fig. 7, E–G). In addition, retinal
iNOS expression was also markedly increased at this age (Fig.
7H), suggesting that there might be overproduction of nitric
oxide (NO) in transgenic retinas. Altogether, these results sug-
gest a raise in oxidative stress in TgIGF-I retinas.
Impaired Glutamate Recycling in TgIGF-I—Persistent gliosis
can impair the recycling by Müller cells of neurotransmitters,
such as glutamate, whose accumulation in the retinal milieu
causes neurotoxicity (30). Glutamine synthetase (GS), which
converts glutamate into glutamine (30), showed reduced activ-
ity in transgenic retinas (Fig. 8A), suggesting impairment in
glutamate detoxification.
Increased Production of Pro-inflammatory Cytokines in
Transgenic Retinas—ActivatedMüller andmicroglial cells have
direct neurotoxic effects through the release of pro-inflamma-
tory cytokines such as TNF- andMCP-1, which can cause the
death of ganglion neurons (31) and photoreceptors (32). Retinal
Tnf- expression was not altered in younger transgenic mice,
but increased substantially (about 7-fold) by 7.5 months of age
(Fig. 8B). Similarly, the measurement of MCP-1 content at 7.5
months of age showed much higher levels (9-fold increase) in
transgenic retinas (Fig. 8C).
DISCUSSION
IGF-I is a pleiotropic growth factor involved in multiple bio-
logical and pathological processes. In addition to the diabetes-
like vascular alterations previously reported for transgenicmice
with increased intraocular IGF-I (14, 15), this study has unrav-
eled a complex phenotype in transgenic retinas involving neu-
ronal and glial cells. TgIGF-Imice showed a progressive decline
in electroretinographic responses and a decrease in specific
neuronal populations that resulted in significantly impaired
neuronal functionality. Markers of retinal stress, gliosis, and
microgliosis were detected at early ages, before major vascular
alterations occur in this model. Transgenic mice also showed
signs of oxidative stress and alterations in glutamate metabo-
FIGURE 6. Increased gliosis inwild-type retinas exposed to recombinant IGF-I. A,GFAP; B, S100b expression levels inWT retinas incubatedwith increasing
concentrations of IGF-I in the presence or absence of wortmannin, an inhibitor of IGF-I downstream signaling. The expression of both markers of gliosis was
increased in the presence of IGF-I, and this effect was abrogated by the addition of wortmannin. Values are expressed as themean S.E. of 3–4 retinas/group.
*, p0.05.
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lism, likely secondary to gliosis. Alterations showed a progres-
sive pattern, worsening as animals aged. These changes in nor-
mal retinal metabolismmay underlie the neuronal dysfunction
observed in transgenic retinas, which would be further exacer-
bated by the increased production of pro-inflammatory cyto-
kines such as TNF- and MCP-1.
In TgIGF-I mice, ERG recordings showed a pattern compat-
ible with progressive retinal neurodegeneration, from normal
responses at 3 months of age to alterations of all recorded
parameters in both scotopic and photopic conditions by 6–7
months and flat ERG in old animals. Histological analysis
showed loss of retinal neurons (rod photoreceptors, bipolar,
ganglion, and amacrine cells) in aged mice, consistent with the
ERGs.Overt retinal dysfunction occurred at an age, 7.5months,
at which 75% of TgIGF-I mice present retinal detachment
(14, 19). However, when neovascularization and retinal detach-
ment are prevented by long term overexpression of the anti-
angiogenic factor Pedf in the retina (19), ERG responses do not
improve. This observation suggests that additional causes con-
tribute to the dysfunction observed in transgenic retinas.
The analysis of the gene expression profile before onset of
neuronal dysfunction in Tg-IGF-I retinas revealed that the
genes whose expression was altered fell into threemain catego-
ries: retinal stress, which included genes involved in the acute-
phase response (APR), gliosis, and angiogenesis. Nearly every
major disease of the retina, including retinitis pigmentosa and
diabetic retinopathy, is associated with reactive gliosis involv-
ingMüller cells (33). This physiological response contributes to
tissue repair and neuroprotection but, if persistent, may also
contribute to tissue damage (33). Likewise, the acute-phase
response is part of the body’s early defense mechanisms after
infection, tissue injury, stress, or neoplasia (34). However,
chronic APR can lead to disturbances in normal physiology
(35). Increased production of acute-phase proteins has been
reported for animal models of ocular pathologies, such as glau-
coma, experimental diabetes, and photoreceptor degeneration
FIGURE 7. Increased oxidative stress in mice with increased intraocular
IGF-I. Analysis of markers of oxidative stress in WT and Tg-IGF-I animals at
different ages. A, levels of oxidized glutathione were higher in transgenic
retinas at all ages studied. Values are expressed as the mean  S.E. of five
animals/group. *, p0.05. B, up-regulation of Nrf2 expression in both young
and old transgenic retinas, determined by quantitative PCR. Values are
expressed as the mean  S.E. of 4–5 animals/group. *, p 0.05. Retinal
expression of the p67Phox (C) and p22Phox (D) regulatory subunits of the
NADPH oxidase enzyme, assessed by quantitative RT-PCR. A marked up-reg-
ulation of both subunitswas observed in transgenicmice at 3 and 7.5months
of age. E–G, retinal expression of the catalytic subunit of NADPH oxidase,
which are expressed in different retinal cell types. E, Nox1; F, Nox2, and
G,Nox4were allmarkedly up-regulated in transgenic retinas at 7.5months of
age. nd, not detected. Values are expressed as mean  S.E. of 4–5 animals/
group. *, p0.05.H, retinal expression by quantitative RT-PCR of the enzyme
iNOS. Therewas amarked increase in iNOS expression in transgenic retinas at
7.5monthsof age. Values are expressed asmean S.E. of 4–5 animals/group.
*, p0.05.
FIGURE8. Impaired retinalglial functionality inmicewith increased intra-
ocular IGF-I. A, retinal GS activity was assayed in WT and TgIGF-I mice by
spectrophotometric monitoring of -glutamyl hydroxamate. GS activity was
significantly reduced in transgenic animals from an early age. Values are
expressed as mean S.E. of 8–13 animals/group. *, p0.05. B, follow up of
retinal TNF-expressionbyquantitativePCR. TNF-wasnoticeably increased
in TgIGF-I at 7.5 months of age. Values are expressed as mean S.E. of 4–5
animals/group. *, p0.05. C, retinal MCP-1 content in 7.5 month-old WT and
TgIGF-Imice analyzedbyWesternblot.MCP-1 levelswere significantly higher
in transgenic retinas. Values are expressed as mean  S.E. of four animals/
group. **, p0.01. tub, tubulin.
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(36–38). In our animalmodel, the increase inAPR gene expres-
sion may have resulted from the up-regulation, at an early age,
of the transcription factor CEBP-, one of the main transcrip-
tional regulators of acute-phase genes (20). IGF-I is also a well
known activator of the transcription factor NF-B (39),
through several signaling pathways, including the Akt pathway,
which is activated in transgenic retinas (15). Promoter analysis
suggested that 6% of the genes altered in the microarray had
target sequences forNF-B.Activation ofNF-B contributes to
the early activation of APR genes, maintained in later stages by
the interaction between CEBP- and CEBP- (20).
In our transgenic mice, high intraocular IGF-I led to
increased expression of acute-phase proteins and markers of
gliosis early in the course of the animal’s life (3 weeks), before
neuronal or vascular phenotypes appear (14, 15), suggesting
that these alterations were a direct consequence of IGF-I and
not secondary responses. The observation of up-regulated
expression of Gfap and S100b in wild-type retinas exposed to
recombinant IGF-I confirmed this hypothesis. Noticeably,
increased levels of S100b, produced by reactive astrocytes, have
been associated with a wide range of pathological conditions of
the CNS, including Alzheimer, epilepsy, and diabetic retinopa-
thy (40–42). S100b, through its binding to the receptor for
AGEs (RAGE), can activate NF-B leading to production of
pro-inflammatory cytokines and ROS in both glial and micro-
glial cells (42, 43). Given that the retinal expression of this gene
is increased early in the life of TgIGF-I (3 weeks), we hypothe-
size that S100b plays an important role in the retinal alterations
of this animal model. Moreover, the fact that S100b exerts its
action through the RAGE the activation of which occurs in
diabetic retinopathy by AGEs (42, 44), may explain in part
the similarities between the ocular phenotype of normogly-
cemic, IGF-I-overexpressing transgenic mice, and diabetic
retinopathy.
Oxidative stress is a causative factor of neuronal death in
neurodegenerative diseases. Oxidized glutathione was signifi-
cantly increased in transgenic retinas at all ages, suggesting the
presence of oxidative stress. Given that TgIGF-I mice are not
hyperglycemic, the source of any oxidative stress in transgenic
retinas would probably result from IGF-I-mediated cell dys-
function. A strong correlation between increased IGF-I signal-
ing and ROS formation has been established in several cell
types, including endothelial cells and neurons, through the acti-
vation of NADPH oxidase (45). The regulatory and also the
catalytic subunits of this enzyme were up-regulated in IGF-I
transgenic retinas. NADPH oxidase is also overexpressed in
activated microglia (46) and astrocytes (29), and NF-B has
been postulated to be responsible for this overexpression in
reactive astrocytes in the ischemia/reperfusion model (47).
Moreover, the up-regulation of iNOS in transgenic eyes sug-
gests increased production ofNO, probably by activatedMüller
and/or microglial cells, contributing to the formation of reac-
tive species. Finally, the up-regulation ofNrf2, a master regula-
tor of endogenous antioxidant protection involved in the
transcriptional control of detoxifying enzymes, may be consid-
ered a compensatory mechanism against oxidative stress in
IGF-I-overexpressing retinas. Indeed, the up-regulation ofNrf2
has been reported after prolonged activation of NF-B (48).
Müller cells maintain the homeostasis of the retinal milieu,
controlling pH, the concentrations of ions, and the recycling of
neurotransmitters, such as glutamate (33). However, all these
essential functions are impaired when gliosis is established.
Glutamate accumulation causes neurotoxicity (30). The retinal
activity of the enzyme GS, which detoxifies glutamate to gluta-
mine, is decreased in experimentalmodels of retinal injury (49).
Similarly, this activity was significantly reduced in transgenic
retinas from an early age, suggesting impaired glutamate detox-
ification. In addition, in situations of retinal injury and gliosis,
activated Müller and microglial cells can produce and secrete
pro-inflammatory cytokines, which may contribute to the dys-
function of the blood-retinal barrier and also cause neuronal
death (31, 50). Among cytokines, TNF- and MCP-1 directly
contribute to neuronal loss (31, 32). In agreement with the
extensive gliosis and microgliosis observed in IGF-I mice, the
levels of TNF- andMCP-1 were considerably increased at 7.5
months of age, when severe loss of vision occurs, according to
ERG measurements and the marked reduction of retinal neu-
rons. The increased production of cytokines may act synergis-
FIGURE 9. Schematic representation summarizing IGF-I actions on IGF-I transgenic retinas. IGF-I has well described prosurvival properties that are
essential for normal neuronal functionality and protection. However, excess IGF-I stimulation induces deleterious processes (gliosis and microgliosis, retinal
and oxidative stress) that contribute to the impairment of neuronal functionality and viability, leading to neurodegeneration. IGF-I pro-survival actions are
unable to counteract neurodegeneration as animals age.
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tically with the impairment of glial supportive functions to
cause neuronal loss in TgIGF-I retinas.
In our model, glial alterations are observed early in the ani-
mals’ life, whereas neuronal loss and functional impairment do
not become evident until mice are 6 months or older. This
probably results from the fact that IGF-I is a pro-survival mol-
ecule for neurons (8). Despite the profound alterations in reti-
nal homeostasis caused by glial dysfunction and oxidative
stress, it is likely that IGF-I overexpression delayed neuronal
death in this environment, preventing neuronal functional
alterations in young TgIGF-I retinas. As animals aged, the pro-
survival effects of IGF-I in the retina were progressively over-
come leading to neurodegeneration (Fig. 9).
In conclusion, high intraocular levels of IGF-I trigger a series
of cellular processes that bring about retinal stress, impair
homeostatic functions of the glia, and lead to neuronal dysfunc-
tion and death. This work highlights the importance that
increased intraocular levels of IGF-I may have in the progres-
sion of diseases such as ischemic or diabetic retinopathy.
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